Outcomes of Patients with EGFR- Mutant Advanced NSCLC in a Developing Country in Southeast Asia.

Soon Hin HowChong-Kin LiamMuhammad Adil Zainal AbidinHarissa H HasbullahLye Mun ThoGwo Fuang HoIbtisam Muhamad NorYong Kek PangKean Fatt HoMuthukkumaran ThiagarajanRoziana AriffinAzlina SamsudinAzza OmarSin Nee TanChoo Khoon OngSing Yang SoonMau-Ern Poh

Published in: Cancer management and research (2022)

m+ advanced NSCLC patients in an Asian cost-restrictive setting may adversely affect the choice of first-line therapy, time on each line of treatment and subsequently the overall survival of patients.

Keyphrases

end stage renal disease
small cell lung cancer
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
adipose tissue
tyrosine kinase
replacement therapy